Familial pancreatic cancer--current knowledge (Q38016055)

27 August 2017

Familial pancreatic cancer--current knowledge (English)

1 reference

27 August 2017

Thomas M Gress

2

0 references

author name string

Detlef K Bartsch

series ordinal

1

1 reference

PubMed ID

22664588

27 August 2017

Peter Langer

series ordinal

3

1 reference

PubMed ID

22664588

27 August 2017

language of work or name

English

0 references

publication date

5 June 2012

1 reference

Nature Reviews Gastroenterology & Hepatology

27 August 2017

1 reference

27 August 2017

9

1 reference

27 August 2017

8

1 reference

27 August 2017

445-453

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2012.111

27 August 2017

0 references

cites work

Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: A position paper from the Italian Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Prevalence of familial pancreatic cancer in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Increased risk of cancer in the Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Cancer risk in mutation carriers of DNA-mismatch-repair genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Risk of pancreatic cancer in families with Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

RISK FACTORS FOR CANCER IN HEREDITARY PANCREATITIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Cigarette Smoking as a Risk Factor for Pancreatic Cancer in Patients With Hereditary Pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Risk of pancreatic cancer in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Advances in counselling and surveillance of patients at risk for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Familial pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Anticipation in familial pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Elevated cancer mortality in the relatives of patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Importance of age of onset in pancreatic cancer kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Evaluation of the 4q32-34 locus in European familial pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Palladin mutation causes familial pancreatic cancer: absence in European families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Absence of deleterious palladin mutations in patients with familial pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

CDKN2A germline mutations in familial pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

ATM mutations in patients with hereditary pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Patient perspective on the value of genetic counselling for familial pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

PancPRO: risk assessment for individuals with a family history of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Inherited pancreatic cancer: surveillance and treatment strategies for affected families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Feasibility and yield of screening in relatives from familial pancreatic cancer families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Screening for pancreatic cancer in a high-risk cohort: an eight-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Pancreas and islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Feasibility of a pancreatic cancer surveillance program from a psychological point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Update of Familial Pancreatic Cancer in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Genetics of pancreatic cancer. From genes to families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Update on familial pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Early prediction of severity in acute pancreatitis using infrared spectroscopy of serum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Familial pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Hereditary pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

An unfavourable prognosis for pancreatic cancer indicates fields of opportunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Evidence for a major gene influencing risk of pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

BRCA2 germline mutations in familial pancreatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

The prevalence of BRCA2 mutations in familial pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

PALB2 mutations in European familial pancreatic cancer families

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

“PancPro” as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Screening and surveillance for hereditary pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

A new indication for pancreas transplantation: high grade pancreatic dysplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2012.111

Germ line Fanconi anemia complementation group C mutations and pancreatic cancer

31 March 2020

1 reference

12 December 2020

Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden)

1 reference

12 December 2020

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

1 reference

12 December 2020

Fanconi anemia gene mutations in young-onset pancreatic cancer

1 reference

12 December 2020

Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.

1 reference

12 December 2020

Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome

1 reference

12 December 2020

Familial pancreatic cancer: clinicopathologic study of 18 nuclear families.

1 reference

12 December 2020

Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.

1 reference

12 December 2020

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility

1 reference

12 December 2020

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.

1 reference

12 December 2020

Adenocarcinoma of the Pancreas in Four Siblings

1 reference

12 December 2020

10.1038/NRGASTRO.2012.111

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22664588